Drawing for INTELLIVAULT

USPTO serial 86851588

INTELLIVAULT

Reviewed by CopyMark Law Group

Reg. 5438710Status 702Registered
Filing date
Status date
Registration date
Apr 3, 2018
Examiner
WATTS-FITZGERALD, CAITLIN C
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with INTELLIVAULT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ken M. Sheets

Ken M. Sheets Whitestone Law1850 Towers Crescent PlazaTysons, VA 22182United States

Goods and services

ClassDescriptionStatusFirst use
010Pharmaceutical dispensing cabinet with RFID tags for storing, locating, and dispensing medications and medical supplies equipped with internal computer software and hardware for locating, managing and tracking inventory of stored medications and medical supplies that are dispensed from the cabinet, and tracking and controlling the personnel that may access and operate the cabinetACTIVEJan 20, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 21, 2024NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Sep 21, 2024C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Sep 21, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 18, 2024E815TEAS SECTION 8 & 15 RECEIVED—
Apr 3, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jul 1, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 1, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 1, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 1, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 1, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 14, 2019TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 3, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 1, 2018SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Feb 28, 2018CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Feb 13, 2018SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Feb 11, 2018AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 31, 2018IUAFUSE AMENDMENT FILED—
Jan 31, 2018EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Dec 23, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 21, 2017EX3GSOU EXTENSION 3 GRANTED—
Dec 21, 2017EXT3SOU EXTENSION 3 FILED—
Dec 21, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 16, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 14, 2017EX2GSOU EXTENSION 2 GRANTED—
Jun 14, 2017EXT2SOU EXTENSION 2 FILED—
Jun 14, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 7, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 5, 2016EX1GSOU EXTENSION 1 GRANTED—
Dec 5, 2016EXT1SOU EXTENSION 1 FILED—
Dec 5, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 5, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 10, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 10, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 20, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 1, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 1, 2016DOCKASSIGNED TO EXAMINER—
Dec 26, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 19, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance